Table 3. Vaccination responses in chronic kidney disease patients stratified by immunosuppressive or hormone therapy status in China from May 2019 to February 2020.
| Response | Taking hormones/immunosuppressants | |
| Yes | No | |
| Note: group with * or † indicates no significant differences between two groups (P>0.05); group with † and * indicates significant differences between two groups (P<0.05). Abbreviation: CKD=chronic kidney disease; GMC=geometric mean concentration; CI=confidence interval. | ||
| GMC, mIU/mL (95% CI) | ||
| IM0-1-6*20 | 1,317.5 (441.2, 2,193.7) | 1,937.0 (663.0, 3,211.0)* |
| IM0-1-2*20 | 189.0 (1.91, 379.8) | 337.7 (203.0, 472.4)† |
| IM0-1-2*60 | 729.0 (154.9, 1,613.0) | 901.4 (260.4, 2,603.3)† |
| P | 0.119 | 0.016 |
| Seroconversion rate, % (95% CI) | ||
| IM0-1-6*20 | 73.3 (55.6, 85.8) | 87.8 (74.4, 94.7) |
| IM0-1-2*20 | 68.9 (50.8, 82.7) | 82.6 (69.3, 90.9) |
| IM0-1-2*60 | 82.9 (67.3, 91.9) | 93.0 (81.4, 97.6) |
| P | 0.413 | 0.327 |
| High-response, % (95% CI) | ||
| IM0-1-6*20 | 60.0 (42.3, 75.4) | 75.6 (60.7, 86.2)* |
| IM0-1-2*20 | 31.0 (17.3, 49.2) | 52.2 (38.1, 65.9)† |
| IM0-1-2*60 | 45.7 (30.5, 61.8) | 79.1 (64.8, 88.6)* |
| P | 0.083 | 0.012 |